Coronary flow reserve and coronary microvascular functions are strongly related to serum uric acid concentrations in healthy adults

被引:37
作者
Erdogan, D [1 ]
Gullu, H
Caliskan, M
Yildirim, I
Ulus, T
Bilgi, M
Yilmaz, S
Muderrisoglu, H
机构
[1] Baskent Univ, Konya Teaching & Med Res Ctr, Dept Cardiol, Konya, Turkey
[2] Baskent Univ, Konya Teaching & Med Res Ctr, Dept Nephrol, Konya, Turkey
[3] Baskent Univ, Konya Teaching & Med Res Ctr, Dept Rheumatol, Konya, Turkey
关键词
coronary artery disease; coronary flow reserve; Doppler echocardiography; uric acid;
D O I
10.1097/00019501-200602000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Uric acid is a well known antioxidant; however, the relationship between serum uric acid levels and oxidative stress-caused disorders including cardiovascular diseases is not clear yet. Transthoracic Doppler echocardiographic measurement of coronary flow reserve is a useful too[ to investigate coronary flow reserve and coronary microvascular functions. In this study, we investigated the possible association between serum uric acid concentrations and coronary flow reserve in healthy adults. Methods One hundred healthy volunteers with normal uric acid levels, between 18 and 55 years of age, were included in this study. The study group was divided into two with regard to the serum uric acid levels. Coronary diastolic peak flow velocities were measured at baseline and after dipyridamole infusion (0.56 mg/kg over 4 min) using echocardiography. Results Coronary flow reserve and hyperemic mean peak flow velocity were significantly greater in participants with lower serum uric acid concentrations (<= 234 mu mol/l for women, <= 302 mu mol/l for men) than in those with higher serum uric acid concentrations (> 234 mu mol/l for women, > 302 mu mol/l for men) (2.91 +/- 0.5 vs. 2.47 +/- 0.5, P < 0.001; 66.8 +/- 11.4 vs. 61.1 +/- 16.5, P=0.04). The baseline mean peak flow velocity was significantly greater in participants with higher serum uric acid concentrations than in those with lower serum uric acid concentrations (24.7 +/- 4.1 vs. 23.1 +/- 2.4, P=0.02). Conclusion Lower serum uric acid concentrations might be regarded as indicative of coronary microvascular and conductance vessel functionality.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 38 条
  • [21] Regulation of xanthine oxidase by nitric oxide and peroxynitrite
    Lee, CI
    Liu, XP
    Zweier, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) : 9369 - 9376
  • [22] URIC-ACID AND CORONARY HEART-DISEASE RISK - EVIDENCE FOR A ROLE OF URIC-ACID IN THE OBESITY-INSULIN RESISTANCE SYNDROME
    LEE, J
    SPARROW, D
    VOKONAS, PS
    LANDSBERG, L
    WEISS, ST
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (03) : 288 - 294
  • [23] Leyva F, 1997, EUR HEART J, V18, P858
  • [24] Modulation of the nitric oxide synthase pathway in atherosclerosis
    Maxwell, AJ
    Tsao, PS
    Cooke, JP
    [J]. EXPERIMENTAL PHYSIOLOGY, 1998, 83 (05) : 573 - 584
  • [25] Mylonas C, 1999, IN VIVO, V13, P295
  • [26] Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men -: A prospective cohort study
    Niskanen, LK
    Laaksonen, DE
    Nyyssönen, K
    Alfthan, G
    Lakka, HM
    Lakka, TA
    Salonen, JT
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (14) : 1546 - 1551
  • [27] Association of serum antioxidant capacity with coronary artery disease in middle-aged men
    Nojiri, S
    Daida, H
    Mokuno, H
    Iwama, Y
    Mae, K
    Ushio, F
    Ueki, T
    [J]. JAPANESE HEART JOURNAL, 2001, 42 (06): : 677 - 690
  • [28] Relations of hyperuricemia with the various components of the Insulin Resistance Syndrome in young black and white adults: The CARDIA study
    Rathmann, W
    Funkhouser, E
    Dyer, AR
    Roseman, JM
    [J]. ANNALS OF EPIDEMIOLOGY, 1998, 8 (04) : 250 - 261
  • [29] Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals
    Regoli, F
    Winston, GW
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 156 (02) : 96 - 105
  • [30] Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
    Ridker, PM
    Wilson, PWF
    Grundy, SM
    [J]. CIRCULATION, 2004, 109 (23) : 2818 - 2825